[Agranulocytosis induced by chloroacetylajmaline (author's transl)].
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced* / Q000175:diagnosis; D000404:Ajmaline / Q000009:adverse effects / Q000031:analogs & derivatives*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male
D000889:Anti-Arrhythmia Agents; D000404:Ajmaline; C008541:17-monochloroacetylajmaline
Caractéristiques des agranulocytoses à la chloroacétylajmaline.